Bay Rivers Group - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 49 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bay Rivers Group ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$5,334
-54.1%
14,0000.0%0.00%
-55.6%
Q2 2023$11,620
-31.4%
14,0000.0%0.01%
-40.0%
Q1 2023$16,940
-39.8%
14,0000.0%0.02%
-46.4%
Q4 2022$28,140
-19.6%
14,0000.0%0.03%
-20.0%
Q3 2022$35,000
-34.0%
14,0000.0%0.04%
-25.5%
Q2 2022$53,00014,0000.05%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Revelation Capital Management, LLC 2,219,951$14,008,00051.22%
ARCH Venture Management, LLC 3,798,926$23,971,0003.43%
Tikvah Management LLC 707,600$4,465,0001.43%
Triatomic Management LP 221,708$1,399,0001.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,612,019$41,722,0000.93%
Perceptive Advisors 3,655,207$23,064,0000.46%
Casdin Capital, LLC 1,442,870$9,105,0000.41%
Orbimed Advisors 2,300,792$14,518,0000.24%
Nicholas Investment Partners, LP 519,885$3,280,0000.23%
Alphabet Inc. 586,584$3,701,0000.12%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders